Clinical Trials on Papillomavirus Infections in Colombia

Total 2565 results

GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Infections, Papillomavirus

Panama, Mexico, Colombia
GlaxoSmithKline

Completed

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Infections, Papillomavirus | Papillomavirus Vaccines

United States, Russian Federation, Canada, Singapore, Netherlands, United Kingdom, Thailand, Australia, Philippines, Mexico, Portugal, Peru
GlaxoSmithKline

Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Infections, Papillomavirus

Canada, Denmark, Hungary, Sweden
Instituto Nacional de Cancerologia, Columbia

Active, not recruiting

Human Papilloma Virus (HPV) Self-collection and Women Adherence

Cervical Cancer | HPV Infection

Colombia
Takeda

Terminated

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Papillomavirus Infections

United States, Canada, Puerto Rico
GlaxoSmithKline

Completed

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Infections, Papillomavirus

Germany, Canada
GlaxoSmithKline

Completed

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Cervical Intraepithelial Neoplasia | Papillomavirus Infection

Taiwan, Germany, Colombia, Honduras, Panama
GlaxoSmithKline

Completed

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Infections, Papillomavirus

Canada, United States, Brazil
GlaxoSmithKline

Completed

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Infections, Papillomavirus

United States, Canada, Singapore, Netherlands, United Kingdom, Russian Federation, Portugal
GlaxoSmithKline

Completed

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Infections, Papillomavirus

Canada, United States
GlaxoSmithKline

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Infections, Papillomavirus | Papillomavirus Vaccines

Germany, Taiwan, Colombia, Panama, Honduras
University of British Columbia
Merck Canada Inc.

Completed

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine (Merck08)

Human Papillomavirus

Canada
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Papillomavirus Infections

United States, Belgium, Brazil, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Spain, Taiwan, Thailand
Merck Sharp & Dohme LLC

Active, not recruiting

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Papillomavirus Infections

United States, Mexico, Colombia, Poland, South Africa, Taiwan
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Infections, Papillomavirus

Germany, Taiwan, Thailand, Canada, Italy
GlaxoSmithKline

Completed

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Infections, Papillomavirus

United States, Canada
Sanotize Research and Development corp.

Completed

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Verruca Plantaris

Canada
National Cancer Institute (NCI)

Completed

Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IVA Cervical Cancer AJCC v6 and v7 | Recurrent Cervical Carcinoma | Human Papillomavirus Infection | Stage IVB Cervical Cancer AJCC v6 and v7

United States, Canada
University of British Columbia
British Columbia Centre for Disease Control

Terminated

A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts

HPV | Genital Warts

Canada
Simon Dobson
Ministry of Health, British Columbia

Completed

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine (BCGov-01)

Cervical Cancer | Genital Warts

Canada
Children's National Research Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Enrolling by invitation

Neurodevelopmental Outcomes in ZIKV-Exposed Children

Child Development | Congenital Zika Syndrome | Zika Virus | Congenital Infection

United States, Colombia
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Infections, Papillomavirus

Taiwan, Spain, Germany, Colombia, France, Sweden, Australia, Korea, Republic of, Honduras, Czech Republic, Norway, Panama
GlaxoSmithKline

Completed

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Infections, Papillomavirus

United States, Spain, Finland, Germany, Taiwan, Belgium, Philippines, Canada, Australia, United Kingdom, Thailand, Brazil, Italy, Mexico
MediGene

Completed

Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts

Condylomata Acuminata

United States, Argentina, Chile, Colombia, Mexico, Peru, Romania
University of Missouri-Columbia

Withdrawn

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis

United States
GlaxoSmithKline

Completed

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

Infections, Papillomavirus

United States, Canada
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Papillomavirus Infections | Coronavirus Disease (COVID-19)

United States
University of North Texas Health Science Center
Vanderbilt University; Universidad del Valle, Colombia

Completed

Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia

Helicobacter Pylori Infection

Colombia
Universidad de Antioquia
United States Agency for International Development (USAID); Bill and Melinda... and other collaborators

Completed

Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (WMP-COL)

Dengue | Zika Virus Infection | Chikungunya Virus Infection

Colombia
GlaxoSmithKline

Completed

Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects

Infections, Papillomavirus

United States, Australia, Finland, Germany, Taiwan, Belgium, Spain, Canada, Thailand, Italy, United Kingdom, Brazil, Philippines
Corporacion para Investigaciones Biologicas
Universidad de Antioquia; Hospital Pablo Tobón Uribe; Universidad Pontificia... and other collaborators

Completed

Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis

Latent Tuberculosis

Colombia
Universidad del Norte

Unknown

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

Urinary Tract Infections | Enterobacteriaceae Infections | Clinical Trial | Carbapenem | Klebsiella Pneumoniae Infection | Infection Due to ESBL Bacteria | Escherichia Coli Infection | Drug Resistance, Bacterial

Colombia
Universidad de la Sabana

Recruiting

Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases. (CAP)

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae Pneumonia | Streptococcus Pneumoniae Infection Invasive

Colombia
Vancouver Island Health Authority

Recruiting

Ceftriaxone as Home IV for Staph Infections

Abscess | Staphylococcal Infections | Diabetic Foot Infection | Osteomyelitis | Vertebral Osteomyelitis | CNS Infection | Septic Arthritis | Coagulase Negative Staphylococcal Infection

Canada
University of British Columbia
British Columbia Cancer Agency

Unknown

TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment

Latent Tuberculosis Infection

Canada
CES University
Nutreva S.A.S.; Foundation Child Care - FAN

Completed

Zinc Sulphate vs. Zinc Amino Acid Chelate (ZAZO)

Diarrhea | Acute Respiratory Infection

Colombia
United Medical Specialties

Recruiting

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient (COVID-19)

SARS-CoV-2 Infection

Colombia
Henry M. Jackson Foundation for the Advancement...
Infectious Diseases Clinical Research Program

Completed

Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits (LTBI)

Latent Tuberculosis Infection

United States
University Health Network, Toronto
Merck Sharp & Dohme LLC; Canadian Institutes of Health Research (CIHR); Ontario... and other collaborators

Terminated

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men (HPV-SAVE)

Anal Cancer | Human Papillomavirus | Anal Dysplasia

Canada
Vancouver Island Health Authority

Unknown

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection

Canada
University of Los Andes, Columbia
United Nations

Completed

Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission (COVPROSHIELD)

SARS-CoV-2 Infection

Colombia
Universidad Nacional de Colombia

Enrolling by invitation

Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia

Covid19 | SARS-CoV2 Infection

Colombia
Baylor College of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); George Washington...

Active, not recruiting

Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

Hookworm Infections

United States
McMaster University

Terminated

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Clostridium Difficile Infection

Canada
Hospital Universitario San Ignacio
Pontificia Universidad Javeriana

Recruiting

P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19

Coronavirus Infection | SARS-CoV 2 | COVID | COVID19

Colombia
Novafem

Completed

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

SARS-CoV-2 Infection | Ovarian Reserve | Blastocyst

Colombia
Fundación Grupo de Investigación en Cuidados Intensivos...

Completed

Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients (COLOSSAL)

Severe Infection

Colombia
Universidad Tecnológica de Pereira
Hospital Universitario San Jorge de Pereira (HUSJ)

Unknown

Wound Antiseptic Study With Hypochlorous Acid & Iodopovidone (WASH)

Surgical Site Infection

Colombia
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation; Queen... and other collaborators

Completed

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Clostridium Difficile Infection

Canada
Fraser Health

Withdrawn

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections (ToPICL)

Skin Diseases, Infectious | Blood Stream Infections

Canada

Clinical Trials on Papillomavirus Infections in Colombia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations